Trimetrexate glucuronate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for trimetrexate glucuronate and what is the scope of freedom to operate?
Trimetrexate glucuronate
is the generic ingredient in one branded drug marketed by Medimmune Oncology and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for trimetrexate glucuronate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Clinical Trials: | 17 |
Patent Applications: | 7,007 |
Formulation / Manufacturing: | see details |
DailyMed Link: | trimetrexate glucuronate at DailyMed |
Recent Clinical Trials for trimetrexate glucuronate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 1 |
Memorial Sloan Kettering Cancer Center | Phase 1 |
Grupo Oncologico Cooperativo del Sur | Phase 2 |
Medical Subject Heading (MeSH) Categories for trimetrexate glucuronate
Anatomical Therapeutic Chemical (ATC) Classes for trimetrexate glucuronate
US Patents and Regulatory Information for trimetrexate glucuronate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medimmune Oncology | NEUTREXIN | trimetrexate glucuronate | INJECTABLE;INJECTION | 020326-001 | Dec 17, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Medimmune Oncology | NEUTREXIN | trimetrexate glucuronate | INJECTABLE;INJECTION | 020326-002 | Jul 31, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for trimetrexate glucuronate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Medimmune Oncology | NEUTREXIN | trimetrexate glucuronate | INJECTABLE;INJECTION | 020326-001 | Dec 17, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Medimmune Oncology | NEUTREXIN | trimetrexate glucuronate | INJECTABLE;INJECTION | 020326-001 | Dec 17, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Medimmune Oncology | NEUTREXIN | trimetrexate glucuronate | INJECTABLE;INJECTION | 020326-002 | Jul 31, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Medimmune Oncology | NEUTREXIN | trimetrexate glucuronate | INJECTABLE;INJECTION | 020326-001 | Dec 17, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |